TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
The latest Chinese medicine rich list is out, quick to watch
 
Author:中国铭铉 企划部  Release Time:2017-9-13 11:05:26  Number Browse:911
 
Medical net September 13 the latest Chinese medicine rich list of rich list, quick check, see if have your boss!

▍ global 109 medicine, China's share of 37

On September 12, the hurun research institute released the 2017 hurun global health rich list. The list of people on the list is $1 billion. The list of the richest people on the list comes from the pharmaceutical industry, and the deadline for wealth calculation is January 15, 2017. This is the first time that the hurun research institute has published a list of the richest people in the world.

A total of 109 healthy millionaires topped the 2017 hurun global rich list, with China leading the list with 37, followed by India's 20 and Switzerland's 16. Divided by cities, Beijing occupies six seats and is the cradle of China's great health rich.

Rupert hoogewerf, a Briton who was the head of China for Forbes magazine's Forbes list, has been compiling the Forbes list for four consecutive years. In 1999, China first launched the "China rich list". And the hurun research institute, which is a special research group compiled by hoogewerf, has a fairly authoritative list.

▍ 37 members, all from scratch

For the rich list of Chinese health, Mr Hoogewerf said: "China's great health, health industry than many people thought it would be China's large number of rich list the world's leading health, although these did not enter the world top 500 enterprises."

The list shows the 37 Chinese billionaires, all of them self-made.

Sun, 59, and his wife, zhong huijuan, ranked ninth among the world's healthy rich. Sun flies a 22 per cent stake in hengrui pharmaceuticals, which has been ranked number one in China for seven consecutive years. Zhao tao, 51, a stepfather, followed. In addition, the bosses of famous pharmaceutical companies such as yangzijiang, corrections and kangmei are listed on the list.

▍ pharmaceutical industry growth is fast, promising

Based on the list, cypress blue is a subdivision of the big health category. Of the 37 richest people, 25 are from traditional pharmaceutical companies, 16 of which are listed in the ministry of industry and information technology's top 100 pharmaceutical industry 2016. There are 5 blood products, 2 raw materials, 2 bio-pharmaceuticals, pharmaceutical companies, instruments, prescription drug marketing and medical care products.

As can be seen from the list of wealth, despite the impact of healthcare reform, the traditional pharmaceutical companies are the leaders of the whole big health sector and the flag bearer. It is also in line with the rapid development of China's pharmaceutical industry.

According to relevant data, since 2001, China has become the largest emerging pharmaceutical market in the world. The total output value of the pharmaceutical industry increased from 994.6 billion yuan in 2009 to 25798 billion yuan in 2014, with an average annual compound growth rate of 20.61 percent, which is higher than the GDP growth rate and is one of the fastest growing sectors in the national economy.

▍ for these drug firms, clapping

No doubt the sunrise industry.

Even if the current drug companies are affected by the two-ticket price and the bidding price, the future looks to the future, as the newly needed medicine, the market increment undoubtedly has great potential. Once this adjustment period is over, the pharmaceutical industry will have a bigger impact, which could create more millionaires.

At the same time, you can see, the rich drug firms, the increase in wealth for the society at the same time, creating a large number of employment opportunities, also let many employees accumulated a certain level of wealth, is here, for the drug firms applaud.

The attached:
 
Previous article:The intellectual property awareness is to be strengthened
Next article:Pharmaceutical companies face a triple antitrust risk under the "two-ticket" system
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粤公网安备 44011202000029号